Eric Severson
@ESeversonMDPhD
Followers
10
Following
3
Media
6
Statuses
11
Exec Dir of Med Affairs at Labcorp Oncology; Hemepath; Dad, Fisherman, Hiker, Gamer. Opinions are mine.
Cary, NC
Joined October 2022
Grant Hogg presents real-work analysis of 10,283 samples to evaluate impact of #genomic data on #MDS prognosis. About 50% of samples from patients with MDS had molecular findings that stratified clinical risk. #precisiononcology #ASH22 @ASH_hematology
0
2
2
Thanks to everyone who attended our @Labcorp Case Study presentation where we reviewed the clinical, morphologic, cytogenetic, and #molecular characteristics of a case with a TP53 biallelic alteration. #ASH22 @ASH_hematology
0
1
5
Getting ready for the #ASH22 meeting with my #ASHaiku:. ASH workshop with me.December 10th, New Orleans.Hemepath with @Labcorp . @ASH_hematology
0
1
2
PCL cases were enriched for the MYD88/CD79B-mutated (MCD) genotype. With #precisiononcology and #CGP options with BTK inhibitors and #immunotherapy may be options for patients with refractory/relapsed disease. @OncJournal.
academic.oup.com
This article reports on the genomic landscape and prevalence of immunotherapy biomarkers, including tumor mutational burden, in a large cohort of patients
0
1
1
We described the genomic landscape and immunotherapy biomarkers in 69 patients with B-cell primary central nervous system lymphoma (PCL), 36 cases of secondary CNS lymphoma and 969 patients with diffuse large B-cell lymphoma.
1
0
1
NTRK breakpoints are difficult to detect due to intron size and partner variety. We performed #CGP on 6730 samples with @OmniSeqInsight’s NGS assay and identified 17 NTRK fusions (NTRK1=6, NTRK2=3, NTRK3=8) in multiple tumor types. Visit our @Labcorp poster #AMPath22 #AMPlifier.
0
0
1
We performed CGP on 3288 samples using @OmniSeqInsight’s NGS assay. We identified 16 NRG1 fusions – with an incidence of 0.4%. RNA sequencing increases the detection rate for NRG1 fusions and offers therapy options for patients. Visit our @Labcorp poster #AMPath22 #AMPlifier
0
2
4
Great turn out today at our @AMPath workshop today @AMPath. We reviewed how a simple blood draw from a patient with cancer can become genomic data and inform #precisiononcology. @PGDx @Labcorp #AMPath22 #AMPlifier
0
8
13
RT @BeccaPrevisMD: Scientific innovation is required to develop better therapeutic options for patients with #ovariancancer. Led by @shreeb….
ovarianresearch.biomedcentral.com
Background Epithelial ovarian cancer (OC) is the most lethal gynecological malignancy and patients present with significant metastatic burden, particularly to the adipose-rich microenvironment of the...
0
2
0
Looking forward to @AMPath’s meeting! Join @Labcorp , @PGDx and I for a free workshop, “Liquid Biopsy – Improving Patient Access to Precision Oncology Through Centralized Services and Decentralized Kitted Solutions.” Register here: #AMPath22 #AMPlifier.
Are you attending #AMP2022? Join our free workshops to learn how we are helping to democratize access to precision oncology for patients with cancer. Register here to save your seat and have a chance to win a door prize.
0
0
2